BD (Becton, Dickinson and Company), a global medical technology firm, announced it will hold an Investor Day on December 10, 2026, in New York. The event will feature presentations by CEO Tom Polen and other executives on the company's business strategy, capital priorities, and long-term outlook, followed by a Q&A session. Attendees can also visit BD's Product Showcase highlighting innovations that support growth. The event requires advance registration, and a live webcast will be available for remote viewers.
BDX shares trade at USD 212.73 on Pluang as of Nov 11, 2026 04:02 WIB, just below its 52-week high of USD 215.25 and well above the 52-week low of USD 140.71. Despite a 1.17% decline in the last day, investor interest remains strong with 100% buy orders on the platform. The stock offers a dividend yield of 1.97%, and the typical hold time is 105 days, indicating steady investor confidence ahead of the December 10 Investor Day.
Abbott Laboratories, Stryker, and Becton Dickinson continue to raise dividends thanks to steady demand for medical devices like syringes and implants. Becton Dickinson leads with 55 consecutive years of dividend increases, supported by strong free ca...
Wells Fargo upgraded Becton, Dickinson and Company (BDX) to an Overweight rating following the company's fiscal Q4 results that beat expectations, with revenue up 5.4% to $5.27 billion and adjusted earnings rising 27.3% to $4.15 per share. Despite th...
